Epidemiological context and importance of hypertension in pediatrics
====================================================================

Arterial hypertension was identified as the major source of combined mortality and morbidity, representing 7% of global disability-adjusted life years.^[@r1]^ The adoption of the BP definitions and normalization of the \"National High Blood Pressure Education Program\" (NHBPEP) 2004^[@r2]^ has standardized the BP classification in the pediatric population. The percentage of children and adolescents diagnosed with AH is estimated to have doubled in the past two decades. The current prevalence of AH in the pediatric population is around 3% to 5%,^[@r3]-[@r5]^ while that of PH reaches 10% to 15%,^[@r3],[@r4],[@r6],[@r7]^ and such values are mainly attributed to the large increase in childhood obesity.^[@r8]^ The etiology of pediatric AH can be either secondary, most often associated with nephropathies, or primary, attributed to genetic causes with environmental influence, predominating in adolescents.

Pediatric AH is usually asymptomatic, but as many as 40% of hypertensive children have LVH at the initial diagnosis of AH. Although oligosymptomatic in childhood, LVH is a precursor of arrhythmias and HF in adults.^[@r9]^ In addition, pediatric AH is associated with the development of other changes in target organs, such as increased carotid IMT, arterial compliance reduction, and retinal arteriolar narrowing. Early diagnosis and treatment of childhood AH are associated with a lower risk for AH and for increased carotid atheromatosis in adult life.^[@r10]^ Therefore, periodical BP measurements in children and adolescents are recommended, even contradicting the U.S. Preventive Services Task Force\'s suggestion, which considers the evidence of benefits of primary AH screening in asymptomatic children and adolescents insufficient to prevent CVD in childhood or adulthood.^[@r11]^

Definitions and diagnosis
=========================

Definition and etiology
-----------------------

Children and adolescents are considered hypertensive when SBP and/or DBP are greater than or equal to the 95^th^ percentile for age, sex and height percentile, on at least three different occasions.^[@r2]^ Prehypertension in children is defined as SBP/DBP ≥ the 90^th^ percentile \< the 95^th^ percentile, and in adolescents as BP levels ≥ 120/80 mm Hg and \< the 95^th^ percentile. Stage 1 AH is considered for readings between the 95^th^ percentile and the 99^th^ percentile plus 5 mm Hg, while stage 2 AH, for readings \> stage 1. The height percentiles can be obtained by using Centers for Disease Control and Prevention\'s (CDC) growth charts.^[@r12]^ In addition, normal and high BP levels for children and adolescents are available in mobile apps, such as PA Kids and Ped(z).

In the pediatric population, WCH and MH can be diagnosed based on established normality criteria for ABPM.^[@r13]^

After a detailed clinical history and physical examination, children and adolescents considered hypertensive should undergo investigation. The younger the child, the greater the chance of secondary AH. Parenchymal, renovascular and obstructive nephropathies account for approximately 60-90% of the cases, and can affect all age groups (infants, children and adolescents), being more prevalent in younger children with higher BP elevations. Endocrine disorders, such as excessive mineralocorticoid, corticoid or catecholamine secretion, thyroid diseases and hypercalcemia associated with hyperparathyroidism, account for approximately 5% of secondary AH cases. Coarctation of the aorta is diagnosed in 2% of the cases, and 5% of secondary AH cases are attributed to other etiologies, such as adverse effects of vasoactive and immunosuppressive drugs, steroid abuse, central nervous system changes, and increased intracranial pressure.

Primary AH is more prevalent in overweight or obese children and adolescents with family history of AH. Currently, primary AH seems to be the most common form of AH in adolescence, being, however, a diagnosis of exclusion, and, in that population, secondary causes should be investigated whenever possible.

Diagnosis
---------

### Method for BP measurement

Measuring BP in children is recommended at every clinical assessment after the age of 3 years, abiding by the standards for BP measurement.^[@r2]^ Children under the age of 3 years should have their BP assessed on specific situations.^[@r2],[@r14]^ For BP measurement, children should be calm and sitting for at least 5 minutes, with back supported and feet on the floor, having refrained from consuming stimulant foods and beverages. The BP should be taken at heart level on the right arm, because of the possibility of coarctation of the aorta. [Table 1](#t1){ref-type="table"} shows the specific recommendations for auscultatory BP measurement in children and adolescents. Whenever BP is high on the upper limbs, SBP should be assessed on the lower limbs. Such assessment can be performed with the patient lying down, with the cuff placed on the calf, covering at least two-thirds of the knee-ankle distance. The SBP reading on the leg can be higher than that on the arm because of the distal pulse amplification phenomenon. A lower SBP reading on the leg as compared to that on the arm suggests coarctation of the aorta.

###### 

Specific recommendations for BP measurement in children and adolescents

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  • Auscultatory method.

  • Use 1^st^ Korotkoff sound for SBP, and 5^th^ Korotkoff sound for DBP.

  • When using the oscillometric device, it requires validation.

  • Detection of AH by use of the oscillometric device requires confirmation with auscultation.

  • Use appropriate cuff size; air bag width: 40% of arm circumference in the middle point between the acromion and olecranon, and air bag length: 80-100% of arm\
  circumference.

  • Conditions under which children \< 3 years old should have BP measured: neonatal intensive care; congenital heart diseases, kidney diseases, treatment with drugs\
  known to raise BP, and evidence of increased intracranial pressure.
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

[Tables 2](#t2){ref-type="table"} and [3](#t3){ref-type="table"} show the BP percentiles by sex, age and height percentile. [Figures 1](#f1){ref-type="fig"} and [2](#f2){ref-type="fig"} show BP values for boys and girls, respectively, from birth to the age of 1 year based on data from the Report of the Second Task Force on Blood Pressure Control in Children - 1987.^[@r15]^

###### 

Blood pressure levels for boys by age and height percentile^[@r2]^

       BP       SBP (mm Hg)   DBP (mm Hg)                                                                
  ---- -------- ------------- ------------- ----- ------ ----- ----- ----- ---- ---- ---- ---- ---- ---- ----
  1    50^th^   80            81            83    85     87    88    89    34   35   36   37   38   39   39
       90^th^   94            95            97    99     100   102   103   49   50   51   52   53   53   54
       95^th^   98            99            101   -103   104   106   106   54   54   55   56   57   58   58
       99^th^   105           106           108   110    112   113   114   61   62   63   64   65   66   66
  2    50^th^   84            85            87    88     90    92    92    39   40   41   42   43   44   44
       90^th^   97            99            100   102    104   105   106   54   55   56   57   58   58   59
       95^th^   101           102           104   106    108   109   110   59   59   60   61   62   63   63
       99^th^   109           110           111   113    115   117   117   66   67   68   69   70   71   71
  3    50^th^   86            87            89    91     93    94    95    44   44   45   46   47   48   48
       90^th^   100           101           103   105    107   108   109   59   59   60   61   62   63   63
       95^th^   104           105           107   109    110   112   113   63   63   64   65   66   67   67
       99^th^   111           112           114   116    118   119   120   71   71   72   73   74   75   75
  4    50^th^   88            89            91    93     95    96    97    47   48   49   50   51   51   52
       90^th^   102           103           105   107    109   110   111   62   63   64   65   66   66   67
       95^th^   106           107           109   111    112   114   115   66   67   68   69   70   71   71
       99^th^   113           114           116   118    120   121   122   74   75   76   77   78   78   79
  5    50^th^   90            91            93    95     96    98    98    50   51   52   53   54   55   55
       90^th^   104           105           106   108    110   111   112   65   66   67   68   69   69   70
       95^th^   108           109           110   112    114   115   116   69   70   71   72   73   74   74
       99^th^   115           116           118   120    121   123   123   77   78   79   80   81   81   82
  6    50th     91            92            94    96     98    99    100   53   53   54   55   56   57   57
       90^th^   105           106           108   110    111   113   113   68   68   69   70   71   72   72
       95^th^   109           110           112   114    115   117   117   72   72   73   74   75   76   76
       99^th^   116           117           119   121    123   124   125   80   80   81   82   83   84   84
  7    50^th^   92            94            95    97     99    100   101   55   55   56   57   58   59   59
       90^th^   106           107           109   111    113   114   115   70   70   71   72   73   74   74
       95^th^   110           111           113   115    117   118   119   74   74   75   76   77   78   78
       99^th^   117           118           120   122    124   125   126   82   82   83   84   85   86   86
  8    50^th^   94            95            97    99     100   102   102   56   57   58   59   60   60   61
       90^th^   107           109           110   112    114   115   116   71   72   72   73   74   75   76
       95^th^   111           112           114   116    118   119   120   75   76   77   78   79   79   80
       99^th^   119           120           122   123    125   127   127   83   84   85   86   87   87   88
  9    50^th^   95            96            98    100    102   103   104   57   58   59   60   61   61   62
       90^th^   109           110           112   114    115   117   118   72   73   74   75   76   76   77
       95^th^   113           114           116   118    119   121   121   76   77   78   79   80   81   81
       99^th^   120           121           123   125    127   128   129   84   85   86   87   88   88   89
  10   50^th^   97            98            100   102    103   105   106   58   59   60   61   61   62   63
       90^th^   111           112           114   115    117   119   119   73   73   74   75   76   77   78
       95^th^   115           116           117   119    121   122   123   77   78   79   80   81   81   82
       99^th^   122           123           125   127    128   130   130   85   86   86   88   88   89   90
  11   50^th^   99            100           102   104    105   107   107   59   59   60   61   62   63   63
       90^th^   113           114           115   J17    119   120   121   74   74   75   76   77   78   78
       95^th^   117           118           119   121    123   124   125   78   78   79   80   81   82   82
       99^th^   124           125           127   129    130   132   132   86   86   87   88   89   90   90
  12   50^th^   101           102           104   106    108   109   110   59   60   61   62   63   63   64
       90^th^   115           116           118   120    121   123   123   74   75   75   76   77   78   79
       95^th^   119           120           122   123    125   127   127   78   79   80   81   82   82   83
       99^th^   126           127           129   131    133   134   135   86   87   88   89   90   90   91
  13   50^th^   104           105           106   108    110   111   112   60   60   61   62   63   64   64
       90^th^   117           118           120   122    124   125   126   75   75   76   77   78   79   79
       95^th^   121           122           124   126    128   129   130   79   79   80   81   82   83   83
       99^th^   128           130           131   133    135   136   137   87   87   88   89   90   91   91
  14   50^th^   106           107           109   111    113   114   115   60   61   62   63   64   65   65
       90^th^   120           121           123   125    126   128   128   75   76   77   78   79   79   80
       95^th^   124           125           127   128    130   132   132   80   80   81   82   83   84   84
       99^th^   131           132           134   136    138   139   140   87   88   89   90   91   92   92
  15   50^th^   109           110           112   113    115   117   117   61   62   63   64   65   66   66
       90^th^   122           124           125   127    129   130   131   76   77   78   79   80   80   81
       95^th^   126           127           129   131    133   134   135   81   81   82   83   84   85   85
       99^th^   134           135           136   138    140   142   142   88   89   90   91   92   93   93
  16   50^th^   111           112           114   116    118   119   120   63   63   64   65   66   67   67
       90^th^   125           126           128   130    131   133   134   78   78   79   80   81   82   82
       95^th^   129           130           132   134    135   137   137   82   83   83   84   85   86   87
       99^th^   136           137           139   141    143   144   145   90   90   91   92   93   94   94
  17   50^th^   114           115           116   118    120   121   122   65   66   66   67   68   69   70
       90^th^   127           128           130   132    134   135   136   80   80   81   82   83   84   84
       95^th^   131           132           134   136    138   139   140   84   85   86   87   87   88   89
       99^th^   139           140           141   143    145   146   147   92   93   93   94   95   96   97

###### 

Blood pressure levels for girls by age and height percentile2

       BP         SBP (mm Hg)       DBP (mm Hg)                                                                      
  ---- -------- ----------------- ----------------- ---------- ----- ----- ----- ----- ---- ---- ---- ---- ---- ---- ----
  1    50^th^   83                84                85         86    88    89    90    38   39   39   40   41   41   42
       90^th^   97                97                98         100   101   102   103   52   53   53   54   55   55   56
       95^th^   100               101               102        104   105   106   107   56   57   57   58   59   59   60
       99^th^   108               108               109        111   112   113   114   64   64   65   65   66   67   67
  2    50^th^   85                85                87         88    89    91    91    43   44   44   45   46   46   47
       90^th^   98                99                100        101   103   104   105   57   58   58   59   60   61   61
       95^th^   102               103               104        105   107   108   109   61   62   62   63   64   65   65
       99^th^   109               110               111        112   114   115   116   69   69   70   70   71   72   72
  3    50^th^   86                87                88         89    91    92    93    47   48   48   49   50   50   51
       90^th^   100               100               102        103   104   106   106   61   62   62   63   64   64   65
       95^th^   104               104               105        107   108   109   110   65   66   66   67   68   68   69
       99^th^   111               111               113        114   115   116   117   73   73   74   74   75   76   76
  4    50^th^   88                88                90         91    92    94    94    50   50   51   52   52   53   54
       90^th^   101               102               103        104   106   107   108   64   64   65   66   67   67   68
       95^th^   105               106               107        108   110   111   112   68   68   69   70   71   71   72
       99^th^   112               113               114        115   117   118   119   76   76   76   77   78   79   79
  5    50^th^   89                90                91         93    94    95    96    52   53   53   54   55   55   56
       90^th^   103               103               105        106   107   109   109   66   67   67   68   69   69   70
       95^th^   107               107               108        110   111   112   113   70   71   71   72   73   73   74
       99^th^   114               114               116        117   118   120   120   78   78   79   79   80   81   81
  6    50^th^   91                92                93         94    96    97    98    54   54   55   56   56   57   58
       90^th^   104               105               106        108   109   110   111   68   68   69   70   70   71   72
       95^th^   108               109               110        111   113   114   115   72   72   73   74   74   75   76
       99^th^   115               116               117        119   120   121   122   80   80   80   81   82   83   83
  7    50^th^   93                93                95         96    97    99    99    55   56   56   57   58   58   59
       90^th^   106               107               108        109   111   112   113   69   70   70   71   72   72   73
       95^th^   110               111               112        113   115   116   116   73   74   74   75   76   76   77
       99^th^   117               118               119        120   122   123   124   81   81   82   82   83   84   84
  8    50^th^   95                95                96         98    99    100   101   57   57   57   58   59   60   60
       90^th^   108               109               110        111   113   114   114   71   71   71   72   73   74   74
       95^th^   112               112               114        115   116   118   118   75   75   75   76   77   78   78
       99^th^   119               120               121        122   123   125   125   82   82   83   83   84   85   86
  9    50^th^   96                97                98         100   101   102   103   58   58   58   59   60   61   61
       90^th^   110               110               112        113   114   116   116   72   72   72   73   74   75   75
       95^th^   114               114               115        117   118   119   120   76   76   76   77   78   79   79
       99^th^   121               121               123        124   125   127   127   83   83   84   84   85   86   87
  10   50^th^   98                99                100        102   103   104   105   59   59   59   60   61   62   62
       90^th^   112               112               114        115   116   118   118   73   73   73   74   75   76   76
       95^th^   116               116               117        119   120   121   122   77   77   77   78   79   80   80
       99^th^   123               123               125        126   127   129   129   84   84   85   86   86   87   88
  11   50^th^   100               101               102        103   105   106   107   60   60   60   61   62   63   63
       90^th^   114               114               116        117   118   119   120   74   74   74   75   76   77   77
       95^th^   118               118               119 -121   122   123   124   78    78   78   79   80   81   81   
       99^th^   125               125               126        128   129   130   131   85   85   86   87   87   88   89
  12   50^th^   102               103               104        105   107   108   109   61   61   61   62   63   64   64
       90^th^   116               116               117        119   120   121   122   75   75   75   76   77   78   78
       95^th^   119               120               121        123   124   125   126   79   79   79   80   81   82   82
       99^th^   127               127               128        130   131   132   133   86   86   87   88   88   89   90
  13   50^th^   104               105               106        107   109   110   110   62   62   62   63   64   65   65
       90^th^   117               118               119        121   122   123   124   76   76   76   77   78   79   79
       95^th^   121               122               123        124   126   127   128   80   80   80   81   82   83   83
       99^th^   128               129               130        132   133   134   135   87   87   88   89   89   90   91
  14   50^th^   106               106               107        109   110   111   112   63   63   63   64   65   66   66
       90^th^   119               120               121        122   124   125   125   77   77   77   78   79   80   80
       95^th^   123               123               125        126   127   129   129   81   81   81   82   83   84   84
       99^th^   130               131               132        133   135   136   136   88   88   89   90   90   91   92
  15   50^th^   107               108               109        110   111   113   113   64   64   64   65   66   67   67
       90^th^   120               121               122        123   125   126   127   78   78   78   79   80   81   81
       95^th^   124               125               126        127   129   130   131   82   82   82   83   84   85   85
       99^th^   131               132               133        134   136   137   138   89   89   90   91   91   92   93
  16   50^th^   108               108               110        111   112   114   114   64   64   65   66   66   67   68
       90^th^   121               122               123        124   126   127   128   78   78   79   80   81   81   82
       95^th^   125               126               127        128   130   131   132   82   82   83   84   85   85   86
       99^th^   132               133               134        135   137   138   139   90   90   90   91   92   93   93
  17   50^th^   108               109               110        111   113   114   115   64   65   65   66   67   67   68
       90^th^   122               122               123        125   126   127   128   78   79   79   80   81   81   82
       95^th^   125               126               127        129   130   131   132   82   83   83   84   85   85   86
       99^th^   133               133               134        136   137   138   139   90   90   91   91   92   93   93

Figure 1Blood pressure levels for boys, from birth to the age of 1 year^97^

Figure 2Blood pressure levels for girls, from birth to the age of 1 year^97^

**Note:** Adolescents with BP ≥ 120/80 mm Hg should be considered prehypertensive, even if the 90^th^ percentile value is greater than that. This can occur for SBP in patients older than 12 years, and for DBP in patients older than 16 years.

For children/adolescents, ABPM is indicated to investigate WCH and MH, and to follow prehypertensive or hypertensive patients up.^[@r13]^ The prevalence of WCH has been reported as between 22% and 32%. The use of ABPM should be restricted to patients with borderline or mild AH, because patients with high office BP readings are more likely to be hypertensive.^[@r16]^

### Anamnesis

A careful recollection of data on birth, growth and development, personal antecedents, and renal, urological, endocrine, cardiac and neurological diseases should be performed. The following patterns should be characterized: physical activity; dietary intake; smoking habit and alcohol consumption; use of steroids, amphetamines, sympathomimetic drugs, tricyclic antidepressants, contraceptives and illicit substances; and sleep history, because sleep disorders are associated with AH, overweight and obesity. In addition, family antecedents for AH, kidney diseases and other CVRF should be carefully assessed.

### Physical examination

On physical examination, BMI should be calculated.^[@r17]^ Growth delay might suggest chronic disease, and persistent tachycardia might suggest hyperthyroidism or pheochromocytoma. Pulse decrease on the lower limbs leads to the suspicion of coarctation of the aorta. Adenoid hypertrophy is associated with sleep disorders. *Acantosis nigricans* suggests insulin resistance and DM. Abdominal fremitus and murmurs can indicate renovascular disease.^[@r18]^

### Complementary tests

Laboratory and imaging tests are aimed at defining the etiology of AH (primary or secondary) and detecting TOD and CVRF associated with AH ([Tables 4](#t4){ref-type="table"} and [5](#t5){ref-type="table"}).^[@r2],[@r14]^

###### 

Initial investigation of children and adolescents with AH

  -------------------------------------------------------------------------------
  Complete blood count
  Renal function and electrolytes (including calcium, phosphorus and magnesium)
  Fasting lipid panel
  Plasma uric acid levels
  Fasting glucose
  Urinalysis and urine culture
  Retinal exam
  Chest X ray
  ECG / Doppler echocardiography
  Renal US with Doppler of renal arteries
  -------------------------------------------------------------------------------

###### 

Complementary tests to confirm the etiology ofsecondary AH in children and adolescents

  ------------------------------------------------------------------------------
  Measurement of urine electrolytes, proteinuria and urine creatinine

  Plasma levels of renin (or plasma renin activity) and aldosterone, salivary\
  cortisol test, PTH, TSH, free T4 and T3

  Hemoglobin electrophoresis

  Specific auto-antibodies: FAN, anti DNA, ANCA p, ANCA c

  Urine catecholamines and metanephrines (or plasma metanephrine) and MIBG\
  scintigraphy
  ------------------------------------------------------------------------------

MIBG: metaiodobenzylguanidine

Target-organ assessment should be performed in all children and adolescents with stage 1 and 2 AH. Sleep study by use of polysomnography or home respiratory polygraphy is indicated for children and adolescents with sleep disorders detected on anamnesis.^[@r2]^ To investigate secondary AH, see Chapter 12.

[Table 5](#t5){ref-type="table"} shows some tests for children and adolescents suspected of having secondary AH.

Therapeutic aspects
===================

In children and adolescents with confirmed AH, therapeutic management is guided by the AH etiology definition, CV risk assessment, and TOD characterization.

Nonpharmacological management
-----------------------------

Nonpharmacological management should be introduced to all pediatric patients with BP levels above the 90^th^ percentile.^[@r2]^ (GR: IIa; LE: C). It includes body weight loss, a physical exercise program, and dietary intervention.^[@r2]^ Body weight reduction yields good results in the treatment of obese hypertensive children,^[@r19]^ similarly to physical exercise, which has better effect on SBP levels.^[@r19]^ Regular aerobic activity is recommended as follows: moderate-intensity physical exercise, 30-60 minutes/day, if possible, every day. Children with AH can practice resistance or localized training, except for weight lifting. Competitive sports are not recommended for patients with uncontrolled stage 2 AH.^[@r20]^ Dietary intervention can comprise sodium restriction,^[@r21]^ and potassium and calcium supplementation; the efficacy in that population, however, is yet to be proven.^[@r22]^

Pharmacological management
--------------------------

Pharmacological therapy should be initiated for children with symptomatic AH, secondary AH, presence of TOD, types 1 and 2 DM, CKD and persistent AH nonresponsive to nonpharmacological therapy.^[@r2]^ (GR: IIa; LE: B). The treatment is aimed at BP reduction below the 95^th^ percentile in non-complicated AH, and BP reduction below the 90^th^ percentile in both complicated AH, characterized by TOD and comorbidities (DM, CKD), and secondary AH.^[@r2]^ (GR: IIa; LE: C). The treatment should begin with a first-line antihypertensive agent, whose dose should be optimized, and, if target BP level is not attained, other pharmacological groups should be added in sequence. A recent systematic review^[@r23]^ has identified neither a randomized study assessing the efficacy of antihypertensive drugs on TOD, nor any consistent dose-response relationship with any drug class assessed.

The adverse events associated with the use of antihypertensive agents for children and adolescents have been usually of mild intensity, such as headache, dizziness, and upper respiratory tract infections. All classes of antihypertensive drugs seem safe, at least in the short run.^[@r23]^ The only randomized, double-blind, controlled study, by Schaefer et al., comparing the efficacy and safety of drugs of parallel groups and assessing hypertensive children on enalapril or valsartan, has shown comparable results regarding the efficacy and safety of both drugs.^[@r24]^

In secondary AH, the antihypertensive drug choice should be in consonance with the pathophysiological principle involved, considering the comorbidities present. For example, non-cardioselective BBs should be avoided in individuals with upper airway reactivity, because of the risk for bronchospasm.^[@r25]^ In pregnancy, ACEIs and ARBs are contraindicated, because of their potential for fetal malformation.^[@r26]^ The use of those drugs for childbearing-age girls should be always accompanied by contraceptive guidance.^[@r26],[@r27]^

For renovascular AH, of ACEIs or ARBs are indicated in association with vasodilators and DIUs. In cases of coarctation of the aorta, in the preoperative period, the initial drug is usually a BB. If the AH persists postoperatively, the BB can be maintained, replaced or associated with an ACEI or ARB. For AH associated with DM and CKD, an ACEI or ARB is initially used. The use of ACEI and ARB relaxes the efferent arteriole, reducing the glomerular capillary hydrostatic pressure, and posing a risk for AKI in situations of hypovolemia. Similarly, those drugs are contraindicated for patients with bilateral renal artery stenosis.^[@r26]-[@r29]^ For obese adults, ACEIs, ARBs, CCBs, BBs and DIUs are effective in reducing BP.^[@r30]^ In adults, ACEIs and ARBs seem to reduce the risk of developing DM and to increase insulin sensitivity.^[@r31]-[@r33]^

[Table 6](#t6){ref-type="table"} shows the updated pediatric doses of the most frequently prescribed hypotensive agents to treat CAH.^[@r2],[@r27],[@r28]^

###### 

Most frequently used oral drugs for management of pediatric chronic arterial hypertension2

  Drug                      Initial dose (mg/kg/dose)     Maximum dose (mg/kg/day)   Interval
  ------------------------- --------------------------- ---------------------------- ----------
  Amlodipine (6-17 years)   0.1                         0.5                          24h
  Nifedipine XL             0.25-0.5                    3 (max:120 mg/day)           12-24h
  Captopril                                                                          
  Children                  0.3-0.5                     6                            8h
  Neonate                   0.03-0.15                   2                            8-24h
  Enalapril                 0.08                        0.6                          12-24h
  Losartan                  0.7 (max: 50 mg/day)        1.4 (max: 100 mg/day)        24h
  Propranolol               1-2                         4 (max: 640 mg/day)          8-12h
  Atenolol                  0.5-1                       2 (max: 100 mg/day)          12-24h
  Furosemide                0.5-2                       6                            4-12h
  Hydrochlorothiazide       1                           3 (max: 50 mg/day)           12h
  Spironolactone            1                           3.3 (max: 100 mg/day)        6-12h
  Clonidine( ≥12 years)     0.2 mg/day                  2.4 mg/day                   12h
  Prazosin                  0.05-0.1                    0.5                          8h
  Hydralazine               0.75                        7.5 (max: 200 mg/day)        6h
  Minoxidil                                                                           
  \< 12 years               0.2                         50 mg/day                    6-8h
  ≥ 12 years                5 mg/day                    100 mg/day                    

max: maximum; h: hour.

Hypertensive crisis
===================

Hypertensive emergency is characterized by acute BP elevation associated with TOD, which can comprise neurological, renal, ocular and hepatic impairment or myocardial failure, and manifests as encephalopathy, convulsions, visual changes, abnormal electrocardiographic or echocardiographic findings, and renal or hepatic failure.^[@r34]^ Hypertensive urgency is described as BP elevation above the 99^th^ percentile plus 5 mm Hg (stage 2), associated with less severe symptoms, in a patient at risk for progressive TOD, with no evidence of recent impairment. Oral drugs are suggested, under monitoring, with BP reduction in 24-48 hours.^[@r2]^ In HE, the BP reduction should occur slowly and progressively: 30% reduction in the programed amount in 6-12 hours, 30% in 24 hours, and final adjustment in 2-4 days.^[@r35]^ Very rapid BP reduction is contraindicated, because it leads to hypotension, failure of self-regulating mechanisms, and likelihood of cerebral and visceral ischemia.^[@r36]^ The HE should be treated exclusively with parenteral drugs. In Brazil, the most frequently used drug for that purpose is SNP, which is metabolized into cyanide, which can cause metabolic acidosis, mental confusion, and clinical deterioration. Thus, SNP administration for more than 24 hours requires monitoring of serum cyanide levels, especially in patients with renal failure.^[@r35],[@r36]^ After patient\'s stabilization with SNP, an oral antihypertensive agent should be initiated, so that the SNP dose can be reduced. The use of SNP should be avoided in pregnant adolescents and patients with central nervous system hypoperfusion.

Special clinical conditions can be managed with more specific hypotensive agents for the underlying disease. Patients with catecholamine-producing tumors can be initially alpha-blocked with phenoxybenzamine, or prazosin if the former is not available, followed by the careful addition of a BB. After BP control and in the absence of kidney or heart dysfunction, a sodium-rich diet is suggested to expand blood volume, usually reduced by the excess of catecholamines, favoring postoperative BP management and reducing the chance of hypotension. An IV short-acting antihypertensive drug should be used for intraoperative BP control. Furosemide is the first-choice drug for HC caused by fluid overload, for example, in patients with kidney disease, such as acute glomerulonephritis. In case of oliguria/anuria, other antihypertensive drugs can be used concomitantly, and dialysis might be necessary for blood volume control. Arterial hypertension associated with the use of cocaine or amphetamines can be treated with lorazepam or other benzodiazepine, which is usually effective to control restlessness and AH. In the presence of a HE, phentolamine, if available, is the drug of choice, and should be used in combination with lorazepam.^[@r37]^

[Table 7](#t7){ref-type="table"} shows the most frequently used drugs in pediatric HE.^[@r38],[@r39]^

###### 

Major pediatric drugs and doses used to control hypertensive emergency^[@r2],95,96^

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Drug                   Route   Dose                                                                        Action beginning   Duration
  ---------------------- ------- --------------------------------------------------------------------------- ------------------ ---------------------------------------------
  Sodium nitroprusside   IV      0.5-10µg/kg/min                                                             Seconds            Only during infusion

  Labetalol              IV      0.25-3 mg/kg/h or Bolus: 0.2-1 mg/kg followed by infusion: 0.25-3 mg/kg/h   2-5 min            2-4 h

  Nicardipine            IV      1-3µg/kg/min                                                                2-5 min            30 min-4 h, the greater, the longer the use

  Hydralazine            IV\     Bolus: 0.2-0.6 mg/kg IV,  IM, max = 20 mg                                   10-30 min          4-12 h
                         IM                                                                                                     

  Esmolol                IV      Attack: 100-500µg/kg followed by infusion: 50-300µg/kg/min                  Seconds            10-30 min

  Phentolamine           IV      Bolus: 0.05-0.1 mg/kg, max = 5 mg/dose                                      Seconds            15-30 min
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IV: intravenous; IM: intramuscular; min: minute; h: hour.

###### 

90^th^ percentile

  ------------- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  SBP           87   101   106   106   106   106   106   106   106   106   106   106   106
  DBP           68   66    63    63    63    66    66    67    68    68    69    69    69
  Height (cm)   51   59    63    66    68    70    72    73    74    76    77    78    80
  Weight (kg)   4    4     5     5     6     7     8     9     9     10    10    11    11
  ------------- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----

Source: Report of the Second Task Force on Blood Pressure Control in Children - 1987. Task Force on Blood Pressure Control in Children. National Heart, Lung and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79(1):1-25.

###### 

90^th^ percentile

  ------------- ---- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  SBP           76   96   101   104   105   106   106   106   106   106   106   106   106
  DBP           68   66   64    64    65    66    66    66    66    67    67    67    67
  Height (cm)   54   56   56    56    61    63    66    68    70    72    74    75    77
  Weight (kg)   4    4    4     5     5     6     7     8     9     9     10    10    11
  ------------- ---- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----

Source: Report of the Second Task Force on Blood Pressure Control in Children - 1987. Task Force on Blood Pressure Control in Children. National Heart, Lung and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79(1):1-25.
